Managed Care
Disease
Management

 

May 2014

Hospitals are hyping better outcomes with the robot, but economics and marketing may be driving the push

Richard Mark Kirkner

Payers attracted by the siren song of this cost-cutting strategy don’t always appreciate its risks and complications

Peter Boland, PhD ; David Gibson, MD

Fine tuning, not abandoning PSA testing, is the approach

Thomas Reinke

Humana CMO looks to Medicare Advantage and quality scores to drive the company toward new relationships with members, providers, and the government

John Marcille

An instance where the ubiquitous “more research is needed” very much sums up the debate

Frank Diamond



Departments
Legislation & Regulation

Estimates for Sovaldi place it in an expensive neighborhood for medications, but the virus it fights moves slowly

John Carroll
Medication Management

There’s still no “magic pill,” but new medications abound. With the disease uncontrolled in millions, it’s time to get utilization management just right.

Thomas Reinke
The Formulary Files
Michael D. Dalzell
Plan Watch

Kaiser Permanente patients who feel that they are part of the care decision process are more likely to stay on antidepressants

Frank Diamond
Tomorrow's Medicine

Otezla (apremilast) sparks hope about treatment, but also concern about depression and suicidal thoughts

Thomas Morrow, MD